IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG’s Medical Laser Growth Platform

IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million plus up to €50 million in earnout consideration. The acquisition aims to create a scaled medical laser platform combining IPG's urology expertise with Lumibird Medical's ophthalmology leadership, expected to add approximately $1 billion in addressable market and be accretive to gross margin, EBITDA, and adjusted EPS. The transaction is expected to close in Q4 2026.